Fortress Biotech, Inc. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Fortress Biotech, Inc. stock issued during period, shares, new issues for the quarter ending 2016-06-30 was 150.56K shares.
- Fortress Biotech, Inc. stock issued during period, shares, new issues for fiscal 2018 was 1.84M shares.
- Fortress Biotech, Inc. stock issued during period, shares, new issues for fiscal 2013 was 10.56M shares, a 314045.25% increase from fiscal 2012.
- Fortress Biotech, Inc. stock issued during period, shares, new issues for fiscal 2012 was 3.36K shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2018-12-31 | 1.84M shares 10-K · filed 2019-03-18 | |
| 2016-06-30 | 150.56K shares 10-Q · filed 2016-08-09 | |
| 2013-12-31 | 10.56M shares 10-K · filed 2014-03-14 | |
| 2012-12-31 | 3.36K shares 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |